Multitarget strategy of GATA3 and high-grade serous ovarian carcinoma: Where are we now?

Abdalla, Mohnad; El-Arabey, Amr Ahmed; Gai, Zhongtao

Abdalla, Mohnad; El-Arabey, Amr Ahmed; Gai, Zhongtao.

Afiliación

Abdalla M; Research Institute of Pediatrics Children's Hospital Affiliated to Shandong University, Jinan Children's Hospital, Jinan, China.
El-Arabey AA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Al-Azhar University, Cairo 11751, Egypt. Electronic address: ph.amrcapa@gmail.com.
Gai Z; Research Institute of Pediatrics Children's Hospital Affiliated to Shandong University, Jinan Children's Hospital, Jinan, China. Electronic address: gaizhongtao@sina.com.

Thromb Res ; 236: 1-3, 2024 Apr.

Article en En | MEDLINE | ID: mdl-38368672

Asunto(s)

Neoplasias Ováricas; Humanos; Femenino; Neoplasias Ováricas/tratamiento farmacológico; Factor de Transcripción GATA3

Palabras clave

Cancer-associated fibroblasts; High-grade serous ovarian carcinoma; Platelets; Stem cells; Tumor-associated macrophages; Venous thrombosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas Límite: Female / Humans Idioma: En Revista: Thromb Res Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google